Parkside Financial Bank & Trust’s RXO RXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.44K Sell
235
-84
-26% -$1.23K ﹤0.01% 1940
2025
Q4
$4.03K Buy
319
+109
+52% +$1.61K ﹤0.01% 1877
2025
Q3
$3.23K Buy
210
+35
+20% +$564 ﹤0.01% 1863
2025
Q2
$2.75K Buy
175
+35
+25% +$531 ﹤0.01% 1890
2025
Q1
$2.67K Buy
140
+13
+10% +$284 ﹤0.01% 1803
2024
Q4
$3.03K Buy
127
+2
+2% +$56 ﹤0.01% 1551
2024
Q3
$3.5K Hold
125
﹤0.01% 1497
2024
Q2
$3.27K Buy
125
+6
+5% +$125 ﹤0.01% 1459
2024
Q1
$2.6K Buy
119
+2
+2% +$43 ﹤0.01% 1469
2023
Q4
$2.72K Sell
117
-2
-2% -$40 ﹤0.01% 1443
2023
Q3
$2.35K Sell
119
-104
-47% -$2.05K ﹤0.01% 1619
2023
Q2
$5.06K Buy
223
+25
+13% +$504 ﹤0.01% 1363
2023
Q1
$3.89K Buy
198
+59
+42% +$1.13K ﹤0.01% 1464
2022
Q4
$2.39K Buy
+139
New +$2.47K ﹤0.01% 1620

Other funds holding RXO

Parkside Financial Bank & Trust's RXO Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its RXO (RXO) stake by 26% in Q1 2026, selling an estimated $1.23K and leaving 235 shares worth $3.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Parkside Financial Bank & Trust first reported a position in RXO in Q4 2022 and has held it in 14 quarters since. The position peaked at $5.06K in Q2 2023. 275 funds tracked by Wall St. Rank hold RXO as of Q1 2026.

  • Parkside Financial Bank & Trust held 235 shares of RXO worth $3.44K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 84 RXO shares in Q1 2026, an estimated $1.23K.
  • RXO made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1940 holding.
  • Parkside Financial Bank & Trust first reported a position in RXO in Q4 2022 and has held it in 14 quarters since.
  • Parkside Financial Bank & Trust's RXO position peaked at $5.06K in Q2 2023.
  • 275 funds tracked by Wall St. Rank held RXO as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.